Current Topics in Geriatric Patient Care

Program Details

  • Intended Audience: Consultant pharmacists or pharmacists interested in geriatric patient care.
  • UAN: 0012-0000-18-021-H01-P
  • CE Hours: 12 Consultant Recertification or General
  • Price: $250.00
  • Dates Available: 7/1/2018-7/1/2021
  • Activity Type: Application
Enroll Now

Summary

This course is an educational resource designed for consulting pharmacists and pharmacists providing patient care to geriatric patients.  This course includes a variety of continuing education modules such as applying Beers Criteria, laws surrounding the use of chemical restraints, appropriate use of inhalers, anticoagulation, pain management, and selected topics in infectious diseases and diabetes.

This home study course is approved by the Florida Board of Pharmacy for 12 consultant recertification hours.  You must complete all 8 modules to receive 12 consultant recertification hours.



Module Summaries and Objectives

Module 1: Applying Beers Criteria in Primary Care and Inpatient Care Settings

This module describes the 2015 Beers Criteria and walks the participant through utilizing the criteria when given a patient case.  The Beers Criteria are applied to both inpatient and outpatient cases, in which drug therapy alternatives, dose reductions, or drug discontinuations are recommended.

Objectives:

  • Utilize the 2015 Beers Criteria to identify potentially inappropriate medications when given a patient case.
  • Recommend an appropriate drug-therapy alternative for a patient prescribed a potentially inappropriate medication taking into account patient-specific characteristics.
  • Recommend dose reductions or discontinuation of medications based on the 2015 Beers Criteria and a patient’s renal function.
  • Select monitoring parameters for potentially inappropriate medications that may be used with caution in older adults according to 2015 Beers Criteria taking into account patient-specific characteristics.

Module 2: Prevention and Management of Shingles in Geriatric Patients

Herpes zoster infections in the elderly are described, including risk factors and signs and symptoms.  Treatment regimens for herpes zoster and postherpetic neuralgia are discussed, as well as shingles vaccine options.

Objectives:

  • Describe the epidemiology of herpes zoster infections.
  • Identify risk factors for the development of herpes zoster in the geriatric patient population.
  • Recognize the signs and symptoms that indicate a patient has herpes zoster or a complication of infection.
  • Recommend an appropriate treatment regimen for a geriatric patient with herpes zoster or postherpetic neuralgia based on patient-specific factors.
  • Differentiate the vaccines available for the prevention of herpes zoster and counsel a patient who is eligible for receipt of the herpes zoster vaccine.

Module 3: Clostridium difficile Infection in the Elderly

The Clostridium difficile program focuses on these infections in the elderly, including risk factors, signs and symptoms, diagnostic tests, and treatment regimens.  Strategies to improve outcomes and prevent transmission of C. difficile are also discussed.

Objectives

  • Describe the epidemiology of C. difficile infections.
  • Identify risk factors for C. difficile infection in the geriatric patient population.
  • Recognize signs and symptoms and diagnostic tests that indicate a patient has C. difficile infection and interpret clinical findings and laboratory data to categorize a patient’s severity of infection.
  • Recommend an appropriate antimicrobial treatment regimen and adjunctive therapy for the treatment of a geriatric patient with C. difficile infection based on patient-specific factors.
  • Develop strategies to improve outcomes of therapy and prevent transmission of C. difficile infection.

Module 4: Laws Surrounding the Use of Chemical Restraints

Medications used as chemical restraints in the elderly are discussed in this program, including laws and regulations for the use of such restraints.  Focus is also given to strategies that can be used to decrease the use of chemical restraints in the elderly.

Objectives:

  • Define chemical restraints.
  • Identify medications used as chemical restraints.
  • Describe regulations surrounding the use of chemical restraints.
  • Identify the consequences of the use of chemical restraints.
  • Describe methods to reduce the use of chemical restraints.

Module 5: Appropriate Use of Inhalers for Patients with Asthma and COPD

Techniques for the appropriate use of the available inhaler devices are discussed in this program, both in written and video format.  After participating in this program, the participant will be able to select an appropriate inhaler device for a patient and counsel the patient on its correct use.

Objectives:

  • Describe the steps for appropriate use for each of the available inhaler devices.
  • Examine a patient’s use of an inhaler and identify inhalation technique errors.
  • Select an optimal inhaler device based on patient specific characteristics.

Module 6:  Anticoagulation for Geriatric Patients

The various oral anticoagulants are discussed in this program, both warfarin and the non-vitamin K oral anticoagulants.  Selection of an appropriate oral anticoagulant medication is reviewed as well as possible reversal strategies for each.

Objectives:

  • Differentiate the therapeutic considerations for warfarin and the non-vitamin K oral anticoagulants (NOACs).
  • Select the most appropriate medication for anticoagulation when given a patient case.
  • Describe the anticoagulation reversal treatment strategies available for anticoagulant medications.
  • Describe the opportunities available within the role of the pharmacist associated with the use of NOACs.

Module 7: Minimizing Risk of Hypoglycemia in the Elderly

Elderly patients with type 2 diabetes are often at higher risk of hypoglycemia.  Strategies to minimize risk of hypoglycemia in patients receiving drug therapy for type 2 diabetes are discussed in this program.  Approaches to managing hypoglycemic episodes are also included in this program.

Objectives:

  • Describe strategies to minimize the risk of hypoglycemia associated with treatment of type 2 diabetes mellitus.
  • Recommend treatments for the management of hypoglycemic episodes.

Module 8: Chronic Pain Management for Geriatric Patients

Various treatment strategies for chronic pain in elderly patients are discussed in this program as well as potential barriers to implementing appropriate pain management strategies in these patients.  The causes of chronic pain and goals of therapy in this patient population are also reviewed here.

Objectives:

  • Describe causes and symptoms of chronic pain in the elderly.
  • Describe appropriate therapies for treatment of chronic pain in the elderly.
  • Identify risks and benefits of therapies for the treatment of chronic pain in the elderly.
  • Describe barriers to implementing appropriate pain management in the elderly.
  • Identify goals of pain management therapy in the elderly.

Acknowledgements and Disclosures

The following speakers, reviewers, and planning committee members have disclosed that he/she has no relevant financial disclosures. No one else in a position to control content has any financial relationships to disclose.

Brandon J. Sucher, Pharm.D., BCACP, CDE, AE-C
Professor of Pharmacy Practice
Regis University School of Pharmacy

Micheline Andel Goldwire, Pharm.D., BCPS
Associate Professor of Pharmacy Practice
Regis University School of Pharmacy

Allana J. Sucher, Pharm.D., BCPS
Professor of Pharmacy Practice
School of Pharmacy, Regis University

Christina T. Nguyen, Pharm.D. Candidate
School of Pharmacy, Regis University

Risa A. Ramirez, Pharm.D Candidate
School of Pharmacy, Regis University

Angela M. Thompson, Pharm.D., BCPS
Assistant Professor of Clinical Pharmacy
School of Pharmacy and Pharmaceutical Sciences, University of Colorado Skaggs

Rhonda Norwood, Pharm.D., BCPS, CDE
Clinical Pharmacy Specialist
Delray Veterans Affairs Community Based Outpatient Clinic
MedMark Services, Inc.

Priti Patel, PharmD, BCPS
Clinical Associate Professor
College of Pharmacy, University of Florida


Schedule of Activities

Review all 8 course modules and pass all 8 post-tests with 70% or more.

Requirements for Successful Course Completion

Review the course material, receive a 70% or higher on all 8 module post-tests, and complete an online program evaluation.

Credit Reporting

  • The University of Florida College of Pharmacy will report CPE credit to CPE Monitor and CE Broker when applicable. If you would like a paper statement of credit, you may print it from your NABP e-profile.
  • All pharmacists and pharmacy technicians maintain their own license and/or certification and it is their responsibility to follow up with the Office of Continuing Education at the University of Florida if any CE credit discrepancies are found.
  • It is at the University’s discretion to award or deny credit to a late claiming participant (i.e. after 60 days of the participant engaging in a CPE activity) as it is the University’s CE activity and the provider needs to ensure the requirements necessary for credit are successfully completed.
  • The University may request access to CPE Monitor® if the activity in question occurred within the previous 6 months and with an appropriate reason for access, i.e. power outage, etc.

Program Financial Support

This course received no outside funding support.

Computer Requirements

Computer and Internet access are required to complete this course. Course content is provided via Canvas.

The minimum hardware, software, and Internet requirements for Canvas can be found here.

Policies

Refund Policy for CE Courses

Privacy and Confidentiality Policy

Copyright

This course in its entirety is copyrighted by the University of Florida Continuing Pharmacy Education and may not be duplicated or reproduced for any other purpose without specific written permission.

For questions or more information, please contact our office.


ACPE logo

The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.